ES2181927T3 - Derivados de 1-metilcarbapenem. - Google Patents

Derivados de 1-metilcarbapenem.

Info

Publication number
ES2181927T3
ES2181927T3 ES96942592T ES96942592T ES2181927T3 ES 2181927 T3 ES2181927 T3 ES 2181927T3 ES 96942592 T ES96942592 T ES 96942592T ES 96942592 T ES96942592 T ES 96942592T ES 2181927 T3 ES2181927 T3 ES 2181927T3
Authority
ES
Spain
Prior art keywords
hydroxi
substituted
replaced
hydrogen atom
metilcarbapenem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96942592T
Other languages
English (en)
Inventor
Isao Kawamoto
Yasuo Shimoji
Katsuya Ishikawa
Katsuhiko Kojima
Hiroshi Yasuda
Satoshi Ohya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Application granted granted Critical
Publication of ES2181927T3 publication Critical patent/ES2181927T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

(CONSTITUCION) UN COMPUESTO 1 - METILCARBAPENEM REPRESENTADO POR LA SIGUIENTE FORMULA (I): EN LA QUE R 1 REPRESENTA UN ATOMO DE HIDROGENO O UN GRUPO ALQUILO INFERIOR; R 2 REPRESENTA UN ATOMO DE HIDROGENO O UN RESIDUO ESTER Y A REPRESENTA UN PROLILAMINOPIRROLIDIN - 1 ILCARBONILO SUSTITUIDO, AMINOALCANOILAMINOPIRROLIDIN - 1 - IL CARBONILO SUSTITUIDO, 1 - HIDROXI - 2 - (AMINOALQUILPIRROLIDIN 1 - ILCARBONIL SUSTITUIDO)ETIL, 1 - HIDROXI - 2 - (PIPERAZIN 1 - ILCARBONIL SUSTITUIDO)ETIL, 1 - HIDROXI - 2 (PIRROLIDINILAMINOCARBONIL SUSTITUIDO)ETIL O SIMILARES; O UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO. (VENTAJAS) LOS COMPUESTOS 1 - METILCARBAPANEM DE LA PRESENTE INVENCION TIENEN UNA ACTIVIDAD ANTIBACTERIANA EXCELENTE Y SON AGENTES UTILES PARA LA PREVENCION O TRATAMIENTO DE ENFERMEDADES INFECCIOSAS.
ES96942592T 1995-12-21 1996-12-20 Derivados de 1-metilcarbapenem. Expired - Lifetime ES2181927T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP33313595 1995-12-21
JP30894096 1996-11-20

Publications (1)

Publication Number Publication Date
ES2181927T3 true ES2181927T3 (es) 2003-03-01

Family

ID=26565749

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96942592T Expired - Lifetime ES2181927T3 (es) 1995-12-21 1996-12-20 Derivados de 1-metilcarbapenem.

Country Status (18)

Country Link
US (1) US6090802A (es)
EP (1) EP0882728B1 (es)
KR (1) KR100386993B1 (es)
CN (1) CN1095843C (es)
AT (1) ATE223411T1 (es)
AU (1) AU711135B2 (es)
CA (1) CA2241092C (es)
CZ (1) CZ298246B6 (es)
DE (1) DE69623497T2 (es)
DK (1) DK0882728T3 (es)
ES (1) ES2181927T3 (es)
HK (1) HK1015766A1 (es)
HU (1) HUP9901376A3 (es)
MX (1) MX9805023A (es)
NO (1) NO310684B1 (es)
NZ (1) NZ324447A (es)
PT (1) PT882728E (es)
WO (1) WO1997023483A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ337532A (en) 1997-02-07 2001-06-29 Kyoto Pharma Ind Carbapenem derivatives useful as an antibiotic
KR100589030B1 (ko) 1998-05-01 2006-06-13 교토 야쿠힝 고교 가부시키가이샤 카르바페넴 유도체, 그 사용 방법 및 그 중간체 화합물
AU1415500A (en) * 1998-12-07 2000-06-26 Sankyo Company Limited 1-methylcarbapenem derivatives
TWI250160B (en) * 1999-07-06 2006-03-01 Sankyo Co Crystalline 1-methylcarbapenem compound
US7041660B2 (en) 1999-07-06 2006-05-09 Sankyo Company, Limited Crystalline 1-methylcarbapenem derivatives
US6531594B2 (en) * 2000-08-24 2003-03-11 Mitsubishi Chemical Corporation Process for producing 1H-3-aminopyrrolidine and derivatives thereof
CN1247581C (zh) * 2000-11-20 2006-03-29 三共株式会社 卡巴培南类抗菌剂的制造方法
MXPA03010607A (es) * 2001-05-21 2004-04-02 Kyoto Pharma Ind Compuesto de carbapenem.
US6673829B2 (en) 2001-09-14 2004-01-06 Novo Nordisk A/S Aminoazetidine,-pyrrolidine and -piperidine derivatives
WO2003024928A2 (en) 2001-09-14 2003-03-27 Novo Nordisk A/S Novel aminoazetidine, -pyrrolidine and -piperidine derivatives
CA2644316A1 (en) * 2003-08-25 2005-03-03 Sankyo Company Limited Crystal of 1-methyl carbapenem compound
CN101180271A (zh) * 2005-03-22 2008-05-14 第一三共株式会社 具有1-烷基吡咯烷结构的碳青霉烯衍生物的制备方法
EP1880997A4 (en) * 2005-05-13 2009-03-11 Daiichi Sankyo Co Ltd 1-METHYLCARBAPENEM COMPOUND CRYSTAL
DK2666774T3 (en) 2008-01-18 2015-03-23 Merck Sharp & Dohme Beta-lactamase INHIBITORS

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1283906C (en) * 1983-05-09 1991-05-07 Makoto Sunagawa .beta.-LACTAM COMPOUNDS AND PRODUCTION THEREOF
JPS62155279A (ja) * 1984-11-08 1987-07-10 Sumitomo Pharmaceut Co Ltd 新規なβ−ラクタム化合物
CA1281720C (en) * 1984-11-08 1991-03-19 Makoto Sunagawa Carbapenem compounds and production thereof
JP3005045B2 (ja) * 1990-02-14 2000-01-31 住友製薬株式会社 新規なβ―ラクタム化合物及びその製造法
TW198034B (es) * 1990-03-27 1993-01-11 Manyu Seiyaku Kk
AU651887B2 (en) * 1991-06-04 1994-08-04 Sankyo Company Limited 1-methylcarbapenem derivatives, their preparation and their use as antibiotics
US5712267A (en) * 1991-06-04 1998-01-27 Sankyo Company,. Limited Carbapenem derivatives, their preparation and their use as antibiotics
JP3048196B2 (ja) * 1991-06-20 2000-06-05 第一製薬株式会社 カルバペネム誘導体
FI103046B (fi) * 1992-03-11 1999-04-15 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten pyrrolidinyylitiokarbapeneemij ohdannaisten valmistamiseksi
JP3411589B2 (ja) * 1992-05-11 2003-06-03 第一製薬株式会社 カルバペネム誘導体
JP3344662B2 (ja) * 1992-09-14 2002-11-11 三共株式会社 カルバペネム−３−カルボン酸誘導体
JPH06199860A (ja) * 1992-09-16 1994-07-19 Sankyo Co Ltd カルバペネム誘導体
AU4912393A (en) * 1993-06-15 1994-12-22 Dong Kook Pharmaceutical Co., Ltd. 1-beta-methyl-2-thiolic carbapenem derivatives
GB9320816D0 (en) * 1993-10-08 1993-12-01 Fujisawa Pharmaceutical Co Novel compounds
DE69714841T2 (de) * 1996-04-26 2003-05-28 Sankyo Co Ein 1-methylcarbapenem-derivat

Also Published As

Publication number Publication date
DE69623497T2 (de) 2003-05-28
AU1171897A (en) 1997-07-17
EP0882728A4 (en) 1999-03-24
CN1095843C (zh) 2002-12-11
HUP9901376A3 (en) 2000-03-28
CN1209130A (zh) 1999-02-24
EP0882728A1 (en) 1998-12-09
CZ298246B6 (cs) 2007-08-01
HUP9901376A2 (hu) 1999-08-30
CA2241092C (en) 2004-04-27
EP0882728B1 (en) 2002-09-04
ATE223411T1 (de) 2002-09-15
NO982873D0 (no) 1998-06-19
MX9805023A (es) 1998-11-30
NO982873L (no) 1998-08-21
DK0882728T3 (da) 2003-01-06
KR19990071960A (ko) 1999-09-27
AU711135B2 (en) 1999-10-07
NO310684B1 (no) 2001-08-13
PT882728E (pt) 2002-11-29
HK1015766A1 (en) 1999-10-22
CZ191898A3 (cs) 1998-09-16
DE69623497D1 (de) 2002-10-10
CA2241092A1 (en) 1997-07-03
US6090802A (en) 2000-07-18
NZ324447A (en) 1999-08-30
KR100386993B1 (ko) 2003-12-18
WO1997023483A1 (en) 1997-07-03

Similar Documents

Publication Publication Date Title
ES2191048T3 (es) Derivados de oxazolidinona y compuestos farmaceuticos que los contienen.
ES2181927T3 (es) Derivados de 1-metilcarbapenem.
ATE303993T1 (de) 4-hydroxychinolin-3-carboxamide und hydrazide als antivirale wirkstoffe
ECSP045104A (es) Ligandos de los receptores de los cannabinoides
ES2141174T3 (es) 4-arilmetiloximetil piperidinas como antagonistas de taquiquinina.
NO950297L (no) Prolinamidderivater
PT1158973E (pt) Utilizacao de derivados de sulfamato para o tratamento dos disturbios do controlo de impulsos
KR950701911A (ko) 피페리딘 유도체를 유효성분으로 하는 말초혈관확장제(peripheral vaso-dilating agent containing piperidine derivative as active ingredient)
TR200101969T2 (tr) Enflamasyon tedavisi için sübstitüe edilmiş benzopiran analogları.
CO4940450A1 (es) Formulaciones farmaceuticas que contienen voriconazol
DE69716810T2 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
ES2156287T3 (es) Derivados de difenilmetilen piperidina.
ES2156933T3 (es) Derivados triciclicos de benzazepina y benzotiazepina.
DE69834500D1 (de) Xanthinderivative zur behandlung von hirnischämie
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
AR025379A1 (es) 9a-azalidas con actividad antibacteriana.
DE60106922D1 (de) Bifunktionelle mittel mit antioxydierender und antiarhytmischer wirkung
GB9126874D0 (en) Medicaments
DE69400352D1 (de) 3- oder 4-Glykosyloxybenzopyranderivat und dieses enthaltende antiallergisches Mittel
MX9302818A (es) Agente para incrementar somatostatina o para inhibir la reduccion de somatostatina.
ES2157498T3 (es) Derivados de triazol o sus sales.
EA200001028A1 (ru) Производные 2"-деоксигигромицина
AR005866A1 (es) Composicion farmaceutica antioxidante
MX9306572A (es) Nuevos compuestos cefem.
AR015458A1 (es) Compuestos de tetrahidrofurano, y composicion farmaceutica que lo contiene.